US STOCKS-MannKind, Magnum Hunter among premarket actives
* Futures off: Dow 13 pts, S&P 3 pts, Nasdaq 6.75 pts
By Chuck Mikolajczak
NEW YORK, Sept 25 (Reuters) - MannKind Corp shares were among the most actively traded in premarket on Thursday, after the company said it had closed a licensing agreement with Sanofi for the development and commercialization of its inhaled insulin product.
MannKind said it will receive a $150 million upfront payment within 10 days of the closing.
Shares were trading up 3.6 percent to $6.30 before the opening bell on volume of over 60,000 shares, putting it in the top-10 most actively traded issues on the Nasdaq.
Magnum Hunter shares were surging 12.8 percent to $6.16 before the opening bell after the company announced its throughput volumes on its Eureka Hunter gas gathering pipeline system.
The gain would mark the biggest percentage jump for the stock since April 2013 should it hold throughout the session. Volume of 128,000 represents about 3.6 percent of its 50-day moving average.
U.S. stock index futures were little changed on Thursday, after the S&P 500 notched its biggest gain in a month, ahead of data on the labor market and durable goods.
The S&P 500 snapped a three-day losing skid on Wednesday in a broad advance, led by healthcare and biotech stocks, with gains in the housing sector also providing support after surprisingly strong data on the sector. Continuación...